gammaCore Alternatives

gammaCore is a prescription non-invasive vagus nerve stimulation (nVNS) device used in headache care, including migraine and cluster headache. People comparing alternatives may be looking at access, prescription requirements, device placement, treatment format, cost structure, or the type of nerve stimulation used.

This guide reviews five gammaCore alternatives, with Cefaly leading as a strong prescription-free, drug-free, non-invasive migraine device for adults seeking both acute and preventive migraine treatment support.

Key Takeaways

• Cefaly is an OTC migraine neuromodulation device, offering prescription-free access in the U.S., Canada, the EU, and other countries.
• Cefaly supports both acute and preventive migraine treatment in one device, with a 60-minute Acute program and a 20-minute daily Prevent program.
• Different devices use different neuromodulation pathways. Cefaly uses external trigeminal nerve stimulation, or e-TNS, while gammaCore uses non-invasive vagus nerve stimulation.
• Cost structures vary by device. Cefaly has a one-time device purchase with replacement electrodes, while prescription devices may involve prescriptions, programs, subscriptions, provider pricing, or insurance coverage.
• Device format matters. Forehead-based, upper-arm, neck, headset, and handheld magnetic-stimulation formats may feel very different in day-to-day use.

1) Cefaly

Best For: Adults comparing a prescription-free, non-invasive, drug-free migraine device for both acute relief support and preventive treatment support

Access: FDA-cleared in the U.S. and available without a prescription in the U.S., Canada, the EU, and other countries

Treatment Format: Reusable external trigeminal nerve stimulation device with a 60-minute Acute program and a 20-minute daily Prevent program

Cefaly is the strongest overall option on this list because it combines prescription-free access, acute and preventive treatment programs, at-home convenience, Cefaly clinical study support, and a structured support ecosystem. It is not a general wellness gadget. It is a medical device indicated for acute treatment of migraine with or without aura in patients 18 years of age or older and preventive treatment of migraine in patients 18 years of age or older.

Cefaly uses external trigeminal nerve stimulation, or e-TNS. The trigeminal nerve is located under the skin of the forehead, and Cefaly stimulates nerve endings through an electrode positioned on the forehead, between and just above the eyebrows.

What Makes Cefaly Stand Out

Cefaly stands out because it is prescription-free, drug-free, reusable, and designed specifically for migraine treatment in adults. Unlike prescription-only device pathways, Cefaly can be purchased directly without waiting for a prescription process or insurance pre-authorization.

Cefaly is supported by 20+ years of research and more than 12 clinical trials. Clinical studies show support for reducing migraine pain and migraine frequency in adults.

The Cefaly ecosystem also includes Cefaly app support where available, treatment tracking, migraine logging, health wearable integrations, HSA/FSA eligibility, financing options, and one-on-one coaching. The Cefaly Migraine Relief app, Cefaly Connected device, and coaching services are not yet available in the EU.

Cefaly also offers a satisfaction guarantee: If you are not satisfied with Cefaly, you can return the device for a refund within 90 calendar days of your product delivery date when purchased directly fromthe official website.

2) Nerivio

Best For: People comparing an upper-arm device format and prescription-based access

Access: Prescription required

Treatment Format: Smartphone-controlled remote electrical neuromodulation device worn on the upper arm

Nerivio uses remote electrical neuromodulation through an upper-arm wearable. This format differs from forehead-based devices because the device is worn away from the head, which may be an important practical consideration for people comparing device placement during migraine attacks.

Nerivio is indicated for acute and/or preventive treatment of migraine with or without aura in patients 8 years of age or older. It is a prescription-use, self-administered device for use in the home environment at the onset of migraine headache or aura for acute treatment, or every other day for preventive treatment.

What Makes It Stand Out

Nerivio offers upper-arm placement, smartphone-controlled treatment, and a pediatric age indication starting at 8 years of age. It is generally discussed as a prescription device for acute and preventive migraine treatment in adults and younger patients, depending on the applicable indication and prescribing context.

Key Comparison Points

• Upper-arm placement rather than forehead, neck, or head placement
• Smartphone app required for device operation
• Prescription-use access model
• Acute and/or preventive migraine treatment indication for patients 8 years of age or older

3) SAVI Dual

Best For: People comparing a prescription single-pulse magnetic stimulation format for acute and preventive migraine treatment

Access: Prescription required

Treatment Format: Portable, handheld single-pulse transcranial magnetic stimulation device placed at the back of the head

SAVI Dual uses single-pulse transcranial magnetic stimulation, or sTMS. The device delivers a brief magnetic pulse at the back of the head.

FDA documentation identifies SAVI Dual Migraine Therapy as indicated for the acute and prophylactic treatment of migraine headache in adolescents 12 years of age and older and adults. It is intended for prescription use only.

What Makes It Stand Out

SAVI Dual uses magnetic stimulation rather than electrical stimulation. 

Key Comparison Points

• Uses sTMS rather than e-TNS, nVNS, REN, or combined occipital-trigeminal stimulation
• Handheld device placed at the back of the head
• Prescription-use access model
• Acute and preventive migraine treatment indication for adolescents 12+ and adults

4) Relivion

Best For: People comparing a prescription headset format that stimulates both occipital and trigeminal nerve branches

Access: Prescription required; currently available in the United States

Treatment Format: Wearable headset using external combined occipital and trigeminal neurostimulation

Relivion MG is a wearable neuromodulation device that stimulates branches of the occipital and trigeminal nerves. Its headset format is different from Cefaly’s forehead-electrode e-TNS format and gammaCore’s neck-based nVNS format.

What Makes It Stand Out

Relivion offers its headset design and combined occipital-trigeminal nerve stimulation format. For people comparing device placement, Relivion involves a broader head-worn format rather than a smaller forehead electrode or upper-arm wearable.

Key Comparison Points

• Prescription-use access model
• Currently available in the United States
• Headset format
• Stimulates branches of both the occipital and trigeminal nerves
• Initial 60-day program pricing listed by Relivion after prescription acquisition

5) HeadaTerm 2

Best For: People comparing another OTC forehead-electrode e-TNS format

Access: OTC in the U.S.

Treatment Format: Forehead-electrode external trigeminal nerve stimulation device

HeadaTerm 2 uses e-TNS, or external trigeminal nerve stimulation, through a forehead-electrode format. WAT Medical/EmeTerm announced in 2024 that HeadaTerm 2 received OTC FDA clearance, making it available without a prescription in the U.S.

What Makes It Stand Out

HeadaTerm 2 is another OTC e-TNS option in the U.S. Its main comparison point is its forehead-electrode device format and prescription-free access.

Key Comparison Points

• OTC access in the U.S.
• Forehead-electrode e-TNS format
• Newer OTC device option in the U.S.
• Practical comparison point for people comparing prescription-free trigeminal nerve stimulation devices

Understanding Different Neuromodulation Technologies

Each gammaCore alternative uses a distinct approach to neuromodulation. The main differences are the nerve pathway, stimulation type, device placement, access model, and treatment format.

External Trigeminal Nerve Stimulation (e-TNS)

Cefaly uses external trigeminal nerve stimulation, or e-TNS. The trigeminal nerve is located under the skin of the forehead, and Cefaly stimulates nerve endings through an electrode positioned on the forehead, between and just above the eyebrows.

HeadaTerm 2 also uses a forehead-electrode e-TNS format.

Cefaly’s e-TNS technology is clinically proven to relieve migraine symptoms and reduce migraine frequency in adults.

Non-Invasive Vagus Nerve Stimulation (nVNS)

gammaCore uses non-invasive vagus nerve stimulation. The device is applied on the side of the neck over the vagus nerve. gammaCore’s access model differs from Cefaly because gammaCore is available by prescription.

Remote Electrical Neuromodulation (REN)

Nerivio uses remote electrical neuromodulation through an upper-arm wearable. This allows treatment away from the head and face, with smartphone-controlled operation.

Single-Pulse Transcranial Magnetic Stimulation (sTMS)

SAVI Dual uses single-pulse transcranial magnetic stimulation. It is a portable, handheld device placed at the back of the head and is intended for prescription use.

External Combined Occipital and Trigeminal Neurostimulation

Relivion MG uses a headset format that stimulates branches of the occipital and trigeminal nerves. This makes its placement and stimulation pattern different from forehead-only e-TNS devices.

How to Compare gammaCore Alternatives

The most useful comparison points are access, treatment purpose, device placement, prescription status, cost structure, and support resources.

Access and Prescription Status

Cefaly and HeadaTerm 2 are OTC options. Cefaly is available without a prescription in the U.S., Canada, the EU, and other countries. HeadaTerm 2 has OTC FDA clearance in the U.S.

Nerivio, SAVI Dual, Relivion, and gammaCore use prescription-based access models.

Acute and Preventive Migraine Treatment Support

Cefaly offers acute and preventive migraine treatment support in one prescription-free device for adults. Its Acute program is a 60-minute session, and its Prevent program is a 20-minute daily session.

Nerivio, SAVI Dual, and gammaCore also include acute and preventive migraine indications in their current positioning, but they use prescription-based access models. Relivion is generally positioned around prescription-based migraine therapy access through its 60-day program.

Device Placement

Cefaly uses a forehead electrode positioned between and just above the eyebrows. HeadaTerm 2 also uses a forehead-electrode e-TNS format. Nerivio is worn on the upper arm. SAVI Dual is placed at the back of the head. Relivion is worn as a headset. gammaCore is applied to the side of the neck.

Cost Structure

Cefaly uses a one-time device purchase model with replacement electrodes. Some prescription devices may involve specialty pharmacy access, provider pricing, insurance coverage, device programs, subscriptions, or prescription-related steps.

The most accurate cost comparison comes from each device’s current official purchase page, prescription program, or manufacturer access pathway at the time of purchase consideration.

Cluster Headache Context

gammaCore remains an important reference point for cluster headache because gammaCore’s official materials describe FDA-cleared indications for migraine and cluster headache. Cefaly is positioned for migraine treatment in adults, not cluster headache treatment.

Frequently Asked Questions

What are the main types of non-invasive neuromodulation devices available for migraine?

Common device categories include external trigeminal nerve stimulation, non-invasive vagus nerve stimulation, remote electrical neuromodulation, single-pulse transcranial magnetic stimulation, and combined occipital-trigeminal neurostimulation. These devices differ by nerve target, stimulation method, placement, access model, and treatment format.

Are there prescription-free migraine neuromodulation devices?

Yes. Cefaly is available without a prescription in the U.S., Canada, the EU, and other countries. HeadaTerm 2 also has OTC FDA clearance in the U.S. Cefaly remains the stronger overall option in this comparison because it combines OTC access, acute and preventive treatment programs, Cefaly clinical study support, app support where available, coaching resources, HSA/FSA eligibility, financing options, and a refund-based satisfaction guarantee for direct purchases.

How is Cefaly different from gammaCore?

Cefaly uses external trigeminal nerve stimulation through a forehead electrode positioned between and just above the eyebrows. gammaCore uses non-invasive vagus nerve stimulation applied to the side of the neck and is available by prescription. Cefaly is available without a prescription and is positioned for acute and preventive migraine treatment in adults.

Can Cefaly be used with migraine medications?

Cefaly is drug-free, so it does not add another medication to a treatment routine. Questions about migraine medications, medication changes, or combining Cefaly with medication-based treatment are best addressed with a healthcare provider.

What are useful comparison points when reviewing gammaCore alternatives?

Useful comparison points include prescription status, device placement, treatment purpose, session format, age indication, cost structure, and support resources. Cefaly stands out in this comparison because it offers prescription-free access, acute and preventive treatment programs, and a support ecosystem built around app-enabled tracking where available, coaching, HSA/FSA eligibility, financing options, and a refund-based satisfaction guarantee for direct purchases.

Who may need individualized clinical guidance before using Cefaly?

People who are pregnant, breastfeeding, have an implanted device, have a cardiac device, have a complex medical history, are changing medications, or are experiencing new or unusual symptoms may need guidance from a healthcare provider. A healthcare provider can help determine whether Cefaly is appropriate for a specific person’s situation.